logo

Perrigo Co. (PRGO)



Trade PRGO now with
  Date
  Headline
2/20/2018 8:22:09 AM Perrigo Confirms Patent Challenge For Generic Version Of Finacea Foam, 15%
2/20/2018 8:03:02 AM Perrigo Co. Names Ronald Winowiecki CFO
2/15/2018 9:21:06 AM Perrigo Co. (PRGO) Declares Quarterly Dividend of $ 0.19, Record Date 3/2/2018
2/15/2018 9:19:45 AM Perrigo Company Declares Quarterly Dividend Of $0.19/shr; Payable March 20/record March 2
1/30/2018 8:18:07 AM Perrigo Receives Tentative Approval From FDA For Generic Version Of Soolantra (ivermectin) Cream, 1%
1/24/2018 7:52:22 AM Perrigo Receives Final FDA Approval Of A Generic Version Of Estrace Cream
1/24/2018 7:49:16 AM Perrigo Unveils Final Approval From US FDA, Launches AB Rated Generic Version Of Epiduo Gel
1/8/2018 1:10:08 AM Perrigo Appoints Uwe Röhrhoff As President & CEO, Effective Jan 15
1/3/2018 8:10:07 AM Perrigo Reports Tentative FDA Approval For Generic Version Of Prolensa Ophthalmic Solution 0.07%
11/27/2017 9:25:16 AM Perrigo Announces Launch Of An AB Rated Generic Version Of Mycolog II Cream
11/27/2017 9:08:27 AM Perrigo Announces Launch Of An AB Rated Generic Version Of Exalgo 32mg Extended Release Tablets C-II
11/21/2017 8:38:15 AM Perrigo Completes Divestiture Of API Business For $110 Mln
11/21/2017 6:34:34 AM SK Capital Completes Acquisition Of Perrigo’s API Business; Changes API Business Name To Wavelength
11/10/2017 6:26:35 AM RBC Capital Markets Upgrades Perrigo Co. (PRGO) To Sector Perform From Underperform With $86 Up From $64 Price Target